Nanoemulsion-templated multilayer nanocapsules for cyanine-type photosensitizer delivery to human breast carcinoma cells.
There is great clinical interest in developing novel nanocarriers for hydrophobic cyanine dyes used as photosensitizing agents in photodynamic therapy (PDT). In the present study we have employed nanoemulsion-templated oil-core multilayer nanocapsules as robust nanocarriers for a cyanine-type photosensitizer IR-786. These nanoproducts were fabricated via layer-by-layer (LbL) adsorption of oppositely charged polyelectrolytes (PEs), i.e., anionic PSS and cationic PDADMAC on nanoemulsion liquid cores created by dicephalic or bulky saccharide-derived cationic surfactants. All nanocapsules, with different thicknesses of the PE shell and average size <200 nm (measured by DLS) demonstrated good capacity for IR-786 encapsulation. The nanocarriers were visualized by SEM and AFM and their photo-induced anticancer effect and cellular internalization in human breast carcinoma MCF-7/WT cells were determined. Biological response of the cell culture, expressed as dark and photocytotoxicity as well as fluorescence of drug molecules loaded in the multilayer vehicles, analyzed by the FACS and CLSM techniques, have indicated that the delivered IR-786 did not aggregate inside the cells and could, therefore, act as an effective third-generation photosensitizing agent. In vitro biological experiments demonstrated that the properties of studied nanostructures depended upon the PE type and the envelope thickness as well as on the surfactant architecture in the nanoemulsion-based templates employed for the nanocapsule fabrication. Similarity of results obtained for stored (three weeks in the dark at room temperature) and freshly-prepared nanocapsules, attests to viability of this stable, promising drug delivery system for poorly water-soluble cyanines useful in PDT.
Faculty of Chemistry, Wroclaw University of Technology, Wybrzeze Wyspianskiego 27, 50-370 Wroclaw, Poland.
Urszula
U
Bazylińska
Jadwiga
J
Pietkiewicz
Jolanta
J
Saczko
Małgorzata
M
Nattich-Rak
Joanna
J
Rossowska
Arnold
A
Garbiec
Kazimiera A
KA
Wilk
D001943:Breast Neoplasms / Q000188:drug therapy; D002232:Carbocyanines / Q000008:administration & dosage* / Q000737:chemistry; D004396:Coloring Agents / Q000008:administration & dosage* / Q000737:chemistry; D004655:Emulsions; D006801:Humans; D007211:Indoles / Q000008:administration & dosage* / Q000737:chemistry; D061986:MCF-7 Cells; D053769:Nanocapsules / Q000008:administration & dosage* / Q000737:chemistry; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000008:administration & dosage* / Q000737:chemistry; D011095:Polyethylenes / Q000737:chemistry; D011137:Polystyrenes / Q000737:chemistry; D000644:Quaternary Ammonium Compounds / Q000737:chemistry; D013501:Surface-Active Agents / Q000737:chemistry
D002232:Carbocyanines; D004396:Coloring Agents; D004655:Emulsions; C577436:IR-786; D007211:Indoles; D053769:Nanocapsules; D017319:Photosensitizing Agents; D011095:Polyethylenes; D011137:Polystyrenes; D000644:Quaternary Ammonium Compounds; D013501:Surface-Active Agents; C041004:poly-N,N-dimethyl-N,N-diallylammonium chloride; C003321:polystyrene sulfonic acid